Literature DB >> 19152211

The role of binding kinetics in therapeutically useful drug action.

David C Swinney1.   

Abstract

Binding kinetics help define how a medicine will communicate with physiology to produce a desired therapeutic response. Clinical efficacy, duration of action, clinical differentiation and safety may all be influenced by binding kinetics. The optimization of binding kinetics can be used to maximize a drug's therapeutic index and thereby decrease drug attrition. The gap between basic scientific principles and the potential medical value of a drug is currently bridged by the use of empirical assays. The value of binding kinetics to drug discovery will be increased through an improved ability to identify optimal kinetic mechanisms and define kinetic structure activity relationships.

Mesh:

Substances:

Year:  2009        PMID: 19152211

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  60 in total

Review 1.  Flexibility and binding affinity in protein-ligand, protein-protein and multi-component protein interactions: limitations of current computational approaches.

Authors:  Pierre Tuffery; Philippe Derreumaux
Journal:  J R Soc Interface       Date:  2011-10-12       Impact factor: 4.118

Review 2.  Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.

Authors:  Georges Vauquelin; Steven J Charlton
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

4.  Simplified models for heterobivalent ligand binding: when are they applicable and which are the factors that affect their target residence time.

Authors:  Georges Vauquelin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-28       Impact factor: 3.000

5.  Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations.

Authors:  Ignasi Buch; Toni Giorgino; Gianni De Fabritiis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

Review 6.  Ligand binding assays at equilibrium: validation and interpretation.

Authors:  Edward C Hulme; Mike A Trevethick
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 7.  Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling.

Authors:  M Bernetti; A Cavalli; L Mollica
Journal:  Medchemcomm       Date:  2017-01-30       Impact factor: 3.597

8.  Dissociation kinetics of the streptavidin-biotin interaction measured using direct electrospray ionization mass spectrometry analysis.

Authors:  Lu Deng; Elena N Kitova; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2012-12-18       Impact factor: 3.109

9.  Label-Free Quantification of Small-Molecule Binding to Membrane Proteins on Single Cells by Tracking Nanometer-Scale Cellular Membrane Deformation.

Authors:  Fenni Zhang; Wenwen Jing; Ashley Hunt; Hui Yu; Yunze Yang; Shaopeng Wang; Hong-Yuan Chen; Nongjian Tao
Journal:  ACS Nano       Date:  2018-02-06       Impact factor: 15.881

10.  Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.

Authors:  Fang Bai; Yechun Xu; Jing Chen; Qiufeng Liu; Junfeng Gu; Xicheng Wang; Jianpeng Ma; Honglin Li; José N Onuchic; Hualiang Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.